Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Safety Follow-up Study of Patients Having Received Infusions of HepaStem

NCT02051049 is registered in ClinicalTrials.gov with Cellaion SA as lead sponsor.

NCT NCT02051049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02051049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Safety Follow-up Study of Patients Having Received Infusions of HepaStem
Lead sponsor
Cellaion SA
Phase
Observational
Overall status
Completed
Start date
March 31, 2013
Completion date
February 28, 2019
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crigler najjar syndrome, urea cycle disorders